Market Size of Global Enteral Feeding Tubes Industry
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| CAGR | > 6.00 % |
| Fastest Growing Market | Asia-Pacific |
| Largest Market | North America |
| Market Concentration | Medium |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Enteral Feeding Tubes Market Analysis
The enteral feeding tubes market is projected to register a CAGR of 6% over the forecast period.
The COVID-19 pandemic has significantly impacted the enteral feeding tube market growth, globally. The intensive care units (ICUs) in hospitals, worldwide, have been witnessing a surge in admissions due to the SARS-CoV-2 induced respiratory failure, leading to the COVID-19 disease. As per a 2020 published report by the American Society for Parenteral and Enteral Nutrition (ASPEN), hospital staff across all the hospitals, worldwide, have been recommended to initiate enteral nutrition to the patients within 24-36 hours of intubation and placement. Thus, the COVID-19 pandemic has increased the need for enteral feeding tubes in hospitals.
The studied market growth can be largely attributed to the factors, such as increasing incidences of chronic disorders, growing prevalence of malnutrition worldwide, and a rise in the number of preterm births. These factors are fueling the demand for enteral feeding tubes.
With increasing incidences of chronic disorders, there is an increased demand for enteral feeding tubes. The nutritional management of patients suffering from disorders, such as Parkinson's disease, Alzheimer's disease, and motor neuron disease, is crucial. In such patients, enteral feeding is a commonly used intervention to provide nutritional support and combat lack of appetite, dysphagia, and physical difficulty in consuming food. As per the Alzheimer's Association report, in 2021, the number of Americans aged 65 years or above suffering from Alzheimer's dementia is 6.2 million, and the number is projected to triple to 12.7 million by 2050. Thus, the increase in incidences of neurological disorders is expected to fuel the need for enteral feeding, thereby, fueling the demand for enteral feeding tubes. Moreover, enteral nutrition is a low-risk and non-invasive therapy and is indicated for patients having a functional gastrointestinal tract as first-line induction therapy. As per a 2020 report by the International Foundation for Gastrointestinal Disorders (IFFGD), 10 to 15% of the population is affected by irritable bowel syndrome, worldwide, including 25 to 45 million people afflicted with the disease in the United States. Thus, with the increase in the incidence of metabolic and gastroenterology disorders, the adoption of enteral feeding is expected to increase, which will boost the demand for enteral feeding tubes.
Additionally, in June 2020, Otsuka Pharmaceutical factory launched a new ENORAS liquid for enteral use (for a feeding tube and oral administration), coffee flavor, and strawberry flavor. Such new product launches are propelling the growth of the market.
However, esophageal ulceration caused by enteral feeding tubes around the gastrostomy site and physical complications such as tube blockage, tube fracture, tube leakage, and mispositioning of the tube is some of the factors impeding the market growth.
